Assessment of Group Peer Support to Children With HIV in Vietnam

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02035969
Recruitment Status : Unknown
Verified January 2014 by Mattias Larsson, Karolinska Institutet.
Recruitment status was:  Recruiting
First Posted : January 14, 2014
Last Update Posted : January 14, 2014
Hanoi Medical University
Information provided by (Responsible Party):
Mattias Larsson, Karolinska Institutet

Brief Summary:
This project aims to assess the effect of group peer support to children with HIV in relation to adherence, virological treatment failure as well as physical development. A randomised controlled trial (RCT) will be used where HIV+ children on antiretroviral treatment (ARV) and their caretakers are randomized into either enhanced treatment support (ETS) through peer supporters or the conventional treatment (CT) according to the guidelines of The National AIDS Control Program. The treatment strategies will be assessed and compared in relation to virological treatment failure as primary endpoint, immunological and clinical (AIDS events and mortality) as secondary endpoints as well as treatment adherence and physical development. The results from this project will lead to an increased knowledge in relation to the impact of enhanced treatment support on adherence, virological suppression and resistance development for children with HIV and have an impact on HIV treatment policies and guidelines for Pediatric HIV in low-income settings globally.

Condition or disease Intervention/treatment
Human Immunodeficiency Virus (HIV) Behavioral: Enhanced Treatment Support (ETS)

  Show Detailed Description

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 520 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Diagnostic
Official Title: A Randomized Controlled Trial to Assess the Effect of Group Peer Support to Children With HIV in Relation to Adherence, Virological Treatment Failure as Well as Physical Development
Study Start Date : December 2013
Estimated Primary Completion Date : January 2016
Estimated Study Completion Date : January 2016

Resource links provided by the National Library of Medicine

MedlinePlus related topics: HIV/AIDS
U.S. FDA Resources

Arm Intervention/treatment
No Intervention: Conventional treatment (CT)
Treatment according to the National Treatment Guidelines in Vietnam including treatment counseling and clinical follow up every three months. The caretaker of the child is responsible that the child will take the drugs and is provided with a pre-packed dosage form for easy remembering
Experimental: Enhanced Treatment Support (ETS)
Treatment according to the National Treatment Guidelines in Vietnam including treatment counselling and clinical follow up every three months. In addition adherence support is provided according to the description under intervention.
Behavioral: Enhanced Treatment Support (ETS)

Peer supporters, who are also caregivers of HIV-infected children, organize peer support group meetings. In the meetings one peer supporter discusses problems related to adherence with caretakers and provides them with information. Another supporter provides children above 3 years of age with age relevant information about their disease and treatment as well as games and play to enhance group bounds. The supporter will also have weekly telephone contact with all caretakers to assess the condition of the child.

For children with poor adherence individual support to caretakers and patients will be arranged to assess the child's condition and reason for poor adherence, in case of complications the supporter gives advice or refers the child for medical checkup.

Primary Outcome Measures :
  1. Virological treatment failure [ Time Frame: 24 months ]
    HIV viral load of 1000 copies/ml

Secondary Outcome Measures :
  1. Immunological treatment failure [ Time Frame: 24 months ]
    • No rise in CD4+ T-cell count after 1 year of treatment
    • 50% decline compared to the highest value
    • CD4+ T-cell count below 100

Other Outcome Measures:
  1. Clinical treatment failure [ Time Frame: 24 months ]
    Occurence or recurrence of stage 4 diseases or conditions after at least 6 months of therapy

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   up to 12 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Children already on first line ART

Exclusion Criteria:

  • Children age above 12 years
  • Children with institutionalized parents
  • Children whose sibling are already included

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT02035969

Contact: Mattias Larsson, MD, PhD +46707663068
Contact: Nguyen Thi Kim Chuc, Ass. Prof.

Hanoi Medical University Recruiting
Hanoi, Vietnam, 01
Contact: Nguyen Thi Kim Chuc, Ass. Prof   
Principal Investigator: Mattias Larsson, MD,PhD         
Principal Investigator: Nguyen Thi Kim Chuc, Assoc. Prof         
Sub-Investigator: Pham Nhat An, Prof.         
Sub-Investigator: Do Duy Cuong, Dr         
Sub-Investigator: Tran Chi Thanh, Msc         
Sponsors and Collaborators
Karolinska Institutet
Hanoi Medical University
Principal Investigator: Mattias Larsson, MD, PhD Karolinska Institutet

Responsible Party: Mattias Larsson, MD, PhD, Karolinska Institutet Identifier: NCT02035969     History of Changes
Other Study ID Numbers: K2012-56X-22028-01-3
First Posted: January 14, 2014    Key Record Dates
Last Update Posted: January 14, 2014
Last Verified: January 2014

Additional relevant MeSH terms:
Immunologic Deficiency Syndromes
Acquired Immunodeficiency Syndrome
HIV Infections
Immune System Diseases
Lentivirus Infections
Retroviridae Infections
RNA Virus Infections
Virus Diseases
Sexually Transmitted Diseases, Viral
Sexually Transmitted Diseases
Slow Virus Diseases